No Increase in Infections or Readmissions in Al Amyloid Patients Who Undergo Heart Transplant
After initial efforts at heart transplantation (HT) in patients with light chain amyloidosis were fraught with poor outcomes, emerging experience with modern chemotherapy regimens has led to a major improvement in outcomes in select centers. Given the systemic nature of the disease and the added immunosuppression in the form of chemotherapy, this study sought to analyze if AL patients undergoing HT had a higher burden of readmissions and infections non-amyloid heart transplant patients.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: R. Araujo-Gutierrez, A. Bhimaraj, A. Guha, I. Hussain, M. Kassi, J.H. Kim, B. Trachtenberg Tags: (697) Source Type: research
More News: Amyloidosis | Cardiology | Chemotherapy | Heart | Heart Transplant | Lung Transplant | Study | Transplant Surgery | Transplants